RxDoctor Payments Data

Daisuke Kaneyuki, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · New York, NYNPI 1700485547

Payments from drug & device makers

What this record shows

This record is dominated by grants: $90,909 of the $92,349 with a category attached, or 98.4%. Abbott accounts for 98.4% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $50,000 and has fallen 97.6% since, to $1,225 in 2025. Among thoracic surgery (cardiothoracic vascular surgery) clinicians in NY with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$92,349in general payments, 2019–2025

Across 14 payments — averaging $6596.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$91K
  • Medtronic$845
  • Abiomed$245
  • Edwards Lifesciences$121
  • Boston Scientific$111
  • Atricure, Inc.$91
  • plus $28 from 1 others

What the payments were for

  • Grants$90,90998%
  • Travel & lodging$8451%
  • Food & beverage$5961%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$92,349 in reported general payments places this provider in the 90th percentile of 383 thoracic surgery (cardiothoracic vascular surgery) providers in New York.

See all thoracic surgery (cardiothoracic vascular surgery) providers in New York →

Medicare billing

Part B allowed, 2024
$37,846
Medicare patients
60
Services billed
183

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other thoracic surgery (cardiothoracic vascular surgery) in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →